Schonfeld Strategic Advisors LLC lowered its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 36.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,800 shares of the specialty pharmaceutical company’s stock after selling 18,200 shares during the quarter. Schonfeld […]